Fragmin Archives | DelveInsight Business Research

Tag: Fragmin

Recent Pharma News

Notizia

May 21, 2019• DelveInsight's Drug Report, DelveInsight's Indication Pipeline Reports, Notizia

US approval to Lundbeck’s Vyepti for preventive migraine care; Esperion’s cholesterol-lowering drug Nexletol receives FDA nod; Karius – a start-up company – raises USD 165 Million – strengthens it liquid biopsy testing
Business Consultant, News, Pharma Consultant
Opioid Withdrawal Syndrome: What happens when a person withdraws from Opiates
Articles, Business Consultant, Pharma Consultant
Booming Healthcare sector in MENA: Lucrative opportunity for Global pharma players
Articles, Business Consultant, Pharma Consultant
Incyte meets endpoint in second atopic dermatitis trial; NeoTX lands USD 45 M series C; Five Prime Therapeutics’ pancreatic cancer a bust
Business Consultant, Pharma Consultant, Pharma news
Cardiovascular Disease: A major cause of health loss and a global burden
Business Consultant, Pharma Consultant, Snippets
Why should every company working on CAR-T therapy attend CAR TCR Summit Europe?
Chimeric Antigen Receptor (CAR) T-cell Therapy
Promising therapies that might shift Wet Age-related Macular Degeneration Market in the next decade
Articles, Business Consultant, Pharma Consultant
Wet Age-Related Macular Degeneration: Unravelling the complex disease with comprehensive R&D
Articles, Business Consultant, Pharma Consultant
J&J collaborates with BARDA; Virus kills pancreatic cancer cells; ALX raises USD 105 million for CD47 drug
Business Consultant, News, Pharma Consultant
The epidemic now has a name: COVID-19
Articles, Business Consultant, Pharma Consultant